Towana Looney, a 53-year-old woman from Alabama, has become the third living person to receive a kidney transplant from a gene-edited pig.
Looney, who donated one of her kidneys to her mother back in 1999, developed kidney failure several years later following a pregnancy complication that caused high blood pressure. She started dialysis treatment in December of 2016 and was put on a waiting list for a kidney transplant soon after, in early 2017.
But it was difficult to find a match. So Looney’s doctors recommended the experimental pig organ as an alternative. After eight years on the waiting list, Looney was authorized to receive the kidney under the US Food and Drug Administration’s expanded access program, which allows people with serious or life-threatening conditions to try experimental treatments.
The pig in question was developed by Revivicor, a United Therapeutics company. The company’s technique involves making 10 gene edits to a pig cell. The edits are made to prevent too much organ growth, curb inflammation, and, importantly, stop the recipient’s immune system from rejecting the organ. The edited pig cell is then placed into a pig egg cell that has had its nucleus removed, and the egg is transferred to the uterus of a sow, which eventually gives birth to a gene-edited piglet.
In theory, once the piglet has grown, its organs can be used for human transplantation. Pig organs are similar in size to human ones, after all. A few years ago, David Bennett Sr. became the first person to receive a heart transplant from such a pig. He died two months after the operation, and the heart was later found to have been infected with a pig virus.
Looney received her pig kidney during a seven-hour operation that took place at NYU Langone Health in New York City on November 25. The surgery was led by Jayme Locke of the US Health Resources & Services Administration and Robert Montgomery of the NYU Langone Transplant Institute.
Looney was discharged from the hospital 11 days after her surgery, to an apartment in New York City. She’ll stay in New York for another three months so she can check in with doctors at the hospital for evaluations.
“It’s a blessing,” Looney said in a statement. “I feel like I’ve been given another chance at life. I cannot wait to be able to travel again and spend more quality time with my family and grandchildren.”
There is a huge unmet need for organs. In the US alone, there more than 100,000 people are waiting for one, and 17 people on the waiting list die every day. Researchers hope that gene-edited animals might provide a new source of organs for such individuals.
Revivicor isn’t the only company working on this. Rival company eGenesis, which has a different approach to gene editing, has used CRISPR to create pigs with around 70 gene edits.
“Transplant is one of the few therapies that can cure a complex disease overnight, yet there are too few organs to provide a cure for all in need,” Locke said in a statement. “The thought that we may now have a solution to the organ shortage crisis for others who have languished on our waiting lists invokes the most welcome of feelings: pure joy!”
Today, Looney is the only person living with a pig organ.
Towana Looney, a 53-year-old woman from Alabama, has become the third living person to receive a kidney transplant from a gene-edited pig.
Looney, who donated one of her kidneys to her mother back in 1999, developed kidney failure several years later following a pregnancy complication that caused high blood pressure. She started dialysis treatment in December of 2016 and was put on a waiting list for a kidney transplant soon after, in early 2017.
But it was difficult to find a match. So Looney’s doctors recommended the experimental pig organ as an alternative. After eight years on the waiting list, Looney was authorized to receive the kidney under the US Food and Drug Administration’s expanded access program, which allows people with serious or life-threatening conditions to try experimental treatments.
The pig in question was developed by Revivicor, a United Therapeutics company. The company’s technique involves making 10 gene edits to a pig cell. The edits are made to prevent too much organ growth, curb inflammation, and, importantly, stop the recipient’s immune system from rejecting the organ. The edited pig cell is then placed into a pig egg cell that has had its nucleus removed, and the egg is transferred to the uterus of a sow, which eventually gives birth to a gene-edited piglet.
In theory, once the piglet has grown, its organs can be used for human transplantation. Pig organs are similar in size to human ones, after all. A few years ago, David Bennett Sr. became the first person to receive a heart transplant from such a pig. He died two months after the operation, and the heart was later found to have been infected with a pig virus.
Looney received her pig kidney during a seven-hour operation that took place at NYU Langone Health in New York City on November 25. The surgery was led by Jayme Locke of the US Health Resources & Services Administration and Robert Montgomery of the NYU Langone Transplant Institute.
Looney was discharged from the hospital 11 days after her surgery, to an apartment in New York City. She’ll stay in New York for another three months so she can check in with doctors at the hospital for evaluations.
“It’s a blessing,” Looney said in a statement. “I feel like I’ve been given another chance at life. I cannot wait to be able to travel again and spend more quality time with my family and grandchildren.”
There is a huge unmet need for organs. In the US alone, there more than 100,000 people are waiting for one, and 17 people on the waiting list die every day. Researchers hope that gene-edited animals might provide a new source of organs for such individuals.
Revivicor isn’t the only company working on this. Rival company eGenesis, which has a different approach to gene editing, has used CRISPR to create pigs with around 70 gene edits.
“Transplant is one of the few therapies that can cure a complex disease overnight, yet there are too few organs to provide a cure for all in need,” Locke said in a statement. “The thought that we may now have a solution to the organ shortage crisis for others who have languished on our waiting lists invokes the most welcome of feelings: pure joy!”
Today, Looney is the only person living with a pig organ.